EFGARTIGIMOD ALFA

EFGARTIGIMOD ALFA was reported 3968 times

EFGARTIGIMOD ALFA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THYMECTOMY 36 0.4091
1 MYASTHENIA GRAVIS CRISIS 455 0.3068
2 VENOUS ANGIOPLASTY 3 0.2500
3 THYMOMA MALIGNANT RECURRENT 3 0.2000
4 PROCEDURAL HEADACHE 64 0.1561
5 ACTIVITIES OF DAILY LIVING ASSESSMENT 2 0.1000
6 MYASTHENIA GRAVIS 785 0.0971
7 BULBAR PALSY 16 0.0578
8 THYMOMA 18 0.0499
9 GASTROSTOMY TUBE REMOVAL 2 0.0400
10 CARDIAC THERAPEUTIC PROCEDURE 2 0.0294
11 SYMPTOM RECURRENCE 174 0.0290
12 CARDIAC DEVICE IMPLANTATION 2 0.0274
13 PLASMAPHERESIS 13 0.0249
14 CAPILLARY NAIL REFILL TEST ABNORMAL 2 0.0192
15 LEFT ATRIAL APPENDAGE CLOSURE IMPLANT 2 0.0180
16 ANGIOGRAM ABNORMAL 2 0.0179
17 POSITIVE AIRWAY PRESSURE THERAPY 5 0.0171
18 ICHTHYOSIS 4 0.0159
19 DEPENDENCE ON RESPIRATOR 6 0.0150
20 OPTIC NERVE COMPRESSION 2 0.0146
21 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 20 0.0139
22 DIAPHRAGM MUSCLE WEAKNESS 2 0.0127
23 PROCEDURAL DIZZINESS 4 0.0124
24 OESOPHAGEAL DILATION PROCEDURE 2 0.0120
25 MECHANICAL VENTILATION 22 0.0116
26 HERPES ZOSTER REACTIVATION 3 0.0115
27 EYELID PTOSIS 116 0.0114
28 MASTICATION DISORDER 34 0.0111
29 EXPOSURE TO EXTREME TEMPERATURE 2 0.0103
30 DROPPED HEAD SYNDROME 4 0.0101
31 DYSPNOEA AT REST 28 0.0097
32 RESPIRATORY MUSCLE WEAKNESS 3 0.0093
33 CHOLELITHOTOMY 2 0.0092
34 METASTASES TO PLEURA 9 0.0086
35 EYE SYMPTOM 3 0.0084
36 CYANOPSIA 5 0.0083
37 TREATMENT DELAYED 14 0.0081
38 BLOOD IMMUNOGLOBULIN G DECREASED 20 0.0081
39 OPHTHALMIC HERPES ZOSTER 14 0.0078
40 SKIN TURGOR DECREASED 3 0.0077
41 EYELID CYST 2 0.0077
42 IMMUNOGLOBULINS ABNORMAL 2 0.0077
43 ANTIBODY TEST ABNORMAL 5 0.0069
44 MENINGOCOCCAL INFECTION 2 0.0063
45 PROCEDURAL NAUSEA 5 0.0062
46 MORPHOEA 3 0.0062
47 PRECANCEROUS CONDITION 4 0.0060
48 HERPES ZOSTER OTICUS 3 0.0059
49 DIVERTICULITIS INTESTINAL PERFORATED 2 0.0056
50 LOWER URINARY TRACT SYMPTOMS 2 0.0055
51 FEEDING TUBE USER 2 0.0055
52 LIVIDITY 2 0.0054
53 THERAPEUTIC PRODUCT INEFFECTIVE 21 0.0054
54 PANCREATIC ENLARGEMENT 2 0.0054
55 THERAPY CHANGE 52 0.0053
56 LUMBAR PUNCTURE 2 0.0053
57 DIAPHRAGMATIC DISORDER 4 0.0052
58 EYE CONTUSION 11 0.0052
59 CHOKING 100 0.0051
60 MUSCLE DISCOMFORT 4 0.0051
61 DEVICE RELATED THROMBOSIS 5 0.0051
62 PANCREATOLITHIASIS 2 0.0050
63 ENDOTRACHEAL INTUBATION 14 0.0050
64 DIPLOPIA 127 0.0049
65 PROCEDURAL VOMITING 3 0.0046
66 CHONDROCALCINOSIS 3 0.0046
67 EHLERS-DANLOS SYNDROME 2 0.0043
68 CENTRAL VENOUS CATHETER REMOVAL 2 0.0043
69 OXYGEN THERAPY 7 0.0043
70 CANCER SURGERY 4 0.0042
71 DYSLALIA 3 0.0041
72 IMMUNODEFICIENCY COMMON VARIABLE 2 0.0041
73 ENDOCARDITIS STAPHYLOCOCCAL 2 0.0041
74 AORTIC VALVE REPLACEMENT 5 0.0040
75 METASTATIC SQUAMOUS CELL CARCINOMA 2 0.0039
76 HYPOGAMMAGLOBULINAEMIA 25 0.0038
77 OPHTHALMOPLEGIA 6 0.0038
78 INFECTED BITE 3 0.0035
79 COLONIC ABSCESS 3 0.0035
80 TRACHEOSTOMY 5 0.0035
81 EPIDIDYMITIS 4 0.0034
82 DOSE CALCULATION ERROR 2 0.0034
83 POOR VENOUS ACCESS 35 0.0034
84 BLOOD ALBUMIN INCREASED 3 0.0034
85 COLON CANCER STAGE IV 2 0.0034
86 SALIVA ALTERED 3 0.0033
87 CATARRH 3 0.0033
88 THERAPEUTIC RESPONSE SHORTENED 92 0.0028
89 NOROVIRUS INFECTION 4 0.0028
90 BLEPHAROSPASM 17 0.0027
91 WHEELCHAIR USER 12 0.0027
92 CATARACT OPERATION 16 0.0027
93 STEROID DIABETES 4 0.0027
94 NEUROLOGICAL DECOMPENSATION 6 0.0026
95 MYASTHENIC SYNDROME 2 0.0026
96 MULTIPLE-DRUG RESISTANCE 8 0.0026
97 ASTHENOPIA 14 0.0025
98 COLOSTOMY 5 0.0025
99 RESPIRATORY SYNCYTIAL VIRUS INFECTION 22 0.0025
100 UPPER RESPIRATORY TRACT INFLAMMATION 3 0.0025
101 HEAT EXHAUSTION 2 0.0025
102 SHOULDER FRACTURE 4 0.0024
103 INTERVERTEBRAL DISC OPERATION 3 0.0024
104 MUSCLE FATIGUE 10 0.0024
105 PHYSICAL DECONDITIONING 6 0.0023
106 HYPERCAPNIA 7 0.0023
107 AMYOTROPHIC LATERAL SCLEROSIS 5 0.0023
108 CENTRAL VENOUS CATHETERISATION 7 0.0023
109 ENDOCRINE OPHTHALMOPATHY 2 0.0023
110 ABSCESS DRAINAGE 2 0.0023
111 DYSARTHRIA 86 0.0023
112 CATHETER SITE PRURITUS 2 0.0023
113 DRUG EFFECT LESS THAN EXPECTED 33 0.0022
114 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
115 ENDOCARDITIS 11 0.0021
116 INTENSIVE CARE 3 0.0021
117 INTUSSUSCEPTION 2 0.0021
118 INFUSION SITE EXTRAVASATION 13 0.0021
119 ANIMAL SCRATCH 2 0.0021
120 NEUROENDOCRINE CARCINOMA OF THE SKIN 2 0.0020
121 HYPOPNOEA 7 0.0020
122 VASCULAR DEVICE INFECTION 9 0.0020
123 DILATED CARDIOMYOPATHY 2 0.0020
124 AUTONOMIC NEUROPATHY 2 0.0020
125 WALKING AID USER 13 0.0020
126 ARTHRODESIS 2 0.0020
127 PERIORBITAL SWELLING 11 0.0019
128 THERAPY NON-RESPONDER 87 0.0019
129 HYPOTONIA NEONATAL 3 0.0019
130 CARPAL TUNNEL DECOMPRESSION 2 0.0019
131 DYSPHAGIA 179 0.0019
132 LOSS OF THERAPEUTIC RESPONSE 6 0.0019
133 NEUROMYOPATHY 2 0.0019
134 ORCHITIS 2 0.0019
135 INFUSION SITE BRUISING 4 0.0019
136 INFUSION SITE MASS 2 0.0018
137 IMMOBILE 8 0.0018
138 THYROID MASS 7 0.0018
139 HYPERVOLAEMIA 9 0.0018
140 SYSTEMIC INFECTION 3 0.0018
141 ANTIBODY TEST POSITIVE 3 0.0018
142 ESSENTIAL TREMOR 2 0.0018
143 THERAPY CESSATION 91 0.0018
144 BLOOD FIBRINOGEN DECREASED 2 0.0018
145 MUSCULAR WEAKNESS 199 0.0017
146 DIVERTICULITIS 48 0.0017
147 THYROIDECTOMY 3 0.0017
148 MUCOSAL HAEMORRHAGE 2 0.0017
149 SPINAL FUSION SURGERY 7 0.0017
150 BLADDER OPERATION 2 0.0017
151 IMMUNOSUPPRESSION 15 0.0017
152 THORACIC VERTEBRAL FRACTURE 5 0.0017
153 BILE DUCT CANCER 2 0.0017
154 CARDIAC ABLATION 3 0.0017
155 COLON OPERATION 2 0.0017
156 HAEMATOLOGICAL INFECTION 4 0.0016
157 LARGE INTESTINE INFECTION 2 0.0016
158 DENTAL CARE 3 0.0016
159 TUNNEL VISION 3 0.0016
160 PARANASAL SINUS DISCOMFORT 6 0.0016
161 INSURANCE ISSUE 24 0.0016
162 NOCTURNAL DYSPNOEA 2 0.0016
163 BILIARY OBSTRUCTION 2 0.0015
164 SPINAL OPERATION 19 0.0015
165 SARS-COV-2 TEST POSITIVE 20 0.0015
166 CARDIAC PACEMAKER INSERTION 9 0.0015
167 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
168 MENINGITIS 10 0.0015
169 IMMUNOGLOBULINS DECREASED 2 0.0015
170 VENOUS THROMBOSIS LIMB 3 0.0015
171 THERAPEUTIC PRODUCT EFFECT DECREASED 65 0.0014
172 CHEST INJURY 3 0.0014
173 DROOLING 10 0.0014
174 CARDIOVERSION 2 0.0014
175 MAST CELL ACTIVATION SYNDROME 2 0.0014
176 FACIAL PARESIS 5 0.0014
177 UPPER RESPIRATORY TRACT INFECTION 65 0.0014
178 OESOPHAGEAL STENOSIS 4 0.0014
179 CEREBELLAR HAEMORRHAGE 2 0.0014
180 CHOLANGIOCARCINOMA 2 0.0013
181 LARGE INTESTINAL OBSTRUCTION 3 0.0013
182 IMPETIGO 2 0.0013
183 PULMONARY MASS 20 0.0013
184 ASTIGMATISM 2 0.0013
185 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
186 COMPRESSION FRACTURE 7 0.0013
187 OVERWEIGHT 7 0.0013
188 EYE ALLERGY 2 0.0013
189 REHABILITATION THERAPY 5 0.0013
190 GASTROSTOMY 2 0.0013
191 ORAL SURGERY 3 0.0013
192 NEPHROLITHIASIS 58 0.0013
193 SINUS OPERATION 3 0.0013
194 ORTHOPNOEA 4 0.0013
195 URINARY TRACT INFECTION 214 0.0013
196 CUSHINGOID 4 0.0012
197 PULSE ABNORMAL 3 0.0012
198 ANTIPHOSPHOLIPID SYNDROME 2 0.0012
199 COSTOCHONDRITIS 2 0.0012
200 SPINAL STENOSIS 5 0.0012
201 THERAPY INTERRUPTED 86 0.0012
202 MYOCARDIAL NECROSIS MARKER INCREASED 2 0.0012
203 DERMATOMYOSITIS 3 0.0012
204 ENDODONTIC PROCEDURE 3 0.0012
205 CERVICAL SPINAL STENOSIS 2 0.0012
206 HERNIA REPAIR 3 0.0012
207 RESPIRATORY TRACT INFECTION 30 0.0012
208 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
209 HOSPITALISATION 175 0.0011
210 PHARYNGEAL SWELLING 11 0.0011
211 PRE-EXISTING CONDITION IMPROVED 7 0.0011
212 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3 0.0011
213 SHOULDER ARTHROPLASTY 3 0.0011
214 PAPILLOEDEMA 5 0.0011
215 SALIVARY HYPERSECRETION 11 0.0011
216 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
217 LUMBAR VERTEBRAL FRACTURE 5 0.0011
218 EYE OPERATION 5 0.0011
219 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 52 0.0011
220 IMPATIENCE 2 0.0011
221 SKIN ABRASION 5 0.0011
222 RESPIRATORY SYMPTOM 3 0.0011
223 HYPOPROTEINAEMIA 2 0.0011
224 FACE INJURY 4 0.0011
225 VITAMIN B12 DECREASED 3 0.0010
226 RALES 6 0.0010
227 SPINAL CORD COMPRESSION 4 0.0010
228 AUTOIMMUNE DISORDER 10 0.0010
229 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
230 RESPIRATION ABNORMAL 7 0.0010
231 PNEUMONIA FUNGAL 4 0.0010
232 BACK INJURY 11 0.0010
233 DYSPNOEA EXERTIONAL 38 0.0010
234 VEIN DISORDER 5 0.0010
235 OROPHARYNGEAL DISCOMFORT 9 0.0010
236 STENT PLACEMENT 8 0.0010
237 COVID-19 174 0.0010
238 PULMONARY CONGESTION 13 0.0010
239 UROSEPSIS 9 0.0010
240 ARTHRITIS BACTERIAL 4 0.0010
241 HERPES ZOSTER 56 0.0010
242 HYPERPARATHYROIDISM 2 0.0010
243 BLOOD BLISTER 3 0.0010
244 INFUSION SITE PRURITUS 3 0.0009
245 SENSITIVITY TO WEATHER CHANGE 5 0.0009
246 FACIAL PARALYSIS 8 0.0009
247 PSEUDOMONAS INFECTION 8 0.0009
248 EXOPHTHALMOS 2 0.0009
249 LANGUAGE DISORDER 2 0.0009
250 PNEUMONIA ASPIRATION 23 0.0009
251 INFECTION SUSCEPTIBILITY INCREASED 2 0.0009
252 ASPIRATION 10 0.0009
253 BEDRIDDEN 12 0.0009
254 GRIP STRENGTH DECREASED 8 0.0009
255 COLONOSCOPY 2 0.0009
256 LIGAMENT RUPTURE 4 0.0009
257 CATHETERISATION CARDIAC 4 0.0009
258 SPEECH DISORDER 47 0.0009
259 GASTROINTESTINAL INFECTION 8 0.0009
260 INFECTIOUS MONONUCLEOSIS 2 0.0009
261 MITRAL VALVE INCOMPETENCE 10 0.0009
262 SUDDEN CARDIAC DEATH 3 0.0009
263 EYE MOVEMENT DISORDER 6 0.0009
264 IMMUNE THROMBOCYTOPENIA 4 0.0009
265 EYELID DISORDER 2 0.0009
266 IMPLANT SITE INFECTION 2 0.0009
267 NECK SURGERY 2 0.0009
268 TIBIA FRACTURE 4 0.0009
269 THERAPY PARTIAL RESPONDER 13 0.0008
270 PAINFUL RESPIRATION 2 0.0008
271 SKIN LACERATION 9 0.0008
272 DENTAL OPERATION 2 0.0008
273 CARTILAGE INJURY 2 0.0008
274 DEVICE INFUSION ISSUE 2 0.0008
275 GASTROINTESTINAL TUBE INSERTION 2 0.0008
276 LOSS OF CONTROL OF LEGS 3 0.0008
277 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 23 0.0008
278 ANAL INCONTINENCE 7 0.0008
279 RIB FRACTURE 16 0.0008
280 SEASONAL ALLERGY 11 0.0008
281 TEMPERATURE INTOLERANCE 8 0.0008
282 CONCUSSION 6 0.0008
283 ORAL INFECTION 3 0.0008
284 BRAIN FOG 12 0.0008
285 NAIL DISCOLOURATION 3 0.0008
286 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
287 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 137 0.0008
288 ANIMAL BITE 2 0.0007
289 ANAL FISTULA 4 0.0007
290 FOOD POISONING 4 0.0007
291 CYSTITIS HAEMORRHAGIC 3 0.0007
292 STRESS FRACTURE 4 0.0007
293 GALLBLADDER OPERATION 3 0.0007
294 POST PROCEDURAL INFECTION 6 0.0007
295 MUSCLE TWITCHING 17 0.0007
296 MIGRAINE WITH AURA 2 0.0007
297 JAW DISORDER 4 0.0007
298 DYSSTASIA 21 0.0007
299 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 51 0.0007
300 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
301 KNEE ARTHROPLASTY 15 0.0007
302 KNEE OPERATION 7 0.0007
303 MUSCULOSKELETAL CHEST PAIN 11 0.0007
304 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
305 OXYGEN SATURATION ABNORMAL 2 0.0007
306 UTERINE HAEMORRHAGE 3 0.0007
307 ABSCESS LIMB 3 0.0007
308 RESPIRATORY DISORDER 21 0.0007
309 PRODUCT DISPENSING ISSUE 3 0.0007
310 ASTHENIA 263 0.0007
311 SEPSIS 78 0.0007
312 SPINAL FRACTURE 14 0.0007
313 CYTOKINE RELEASE SYNDROME 14 0.0007
314 TENSION HEADACHE 3 0.0007
315 MUSCULOSKELETAL DISCOMFORT 12 0.0007
316 CORONARY ARTERY BYPASS 4 0.0007
317 CELLULITIS 35 0.0007
318 FIBULA FRACTURE 2 0.0007
319 TONGUE DISORDER 5 0.0007
320 MONOPLEGIA 3 0.0007
321 STRESS CARDIOMYOPATHY 4 0.0007
322 MUSCLE TIGHTNESS 11 0.0007
323 COVID-19 PNEUMONIA 8 0.0007
324 FALL 224 0.0007
325 CATARACT 40 0.0007
326 IMMUNODEFICIENCY 10 0.0007
327 ATYPICAL PNEUMONIA 2 0.0007
328 KIDNEY INFECTION 13 0.0007
329 LACRIMATION INCREASED 20 0.0007
330 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
331 DISEASE COMPLICATION 3 0.0007
332 DIABETIC FOOT 2 0.0007
333 DEVICE RELATED INFECTION 10 0.0006
334 BRAIN DEATH 2 0.0006
335 RENAL FUNCTION TEST ABNORMAL 3 0.0006
336 SECRETION DISCHARGE 8 0.0006
337 SKIN TIGHTNESS 3 0.0006
338 ATRIAL FIBRILLATION 62 0.0006
339 INFUSION SITE SWELLING 4 0.0006
340 COLITIS MICROSCOPIC 3 0.0006
341 DYSPHONIA 37 0.0006
342 NERVE INJURY 7 0.0006
343 HYPERTENSIVE CRISIS 7 0.0006
344 BILE DUCT STONE 2 0.0006
345 PRODUCTIVE COUGH 30 0.0006
346 SUBCUTANEOUS ABSCESS 3 0.0006
347 HEAD DISCOMFORT 11 0.0006
348 MICTURITION URGENCY 7 0.0006
349 INTERNAL HAEMORRHAGE 7 0.0006
350 JOINT INJURY 13 0.0006
351 BREATH SOUNDS ABNORMAL 3 0.0006
352 INFUSION SITE HAEMORRHAGE 2 0.0006
353 NEAR DEATH EXPERIENCE 2 0.0006
354 CORONAVIRUS INFECTION 4 0.0006
355 SPINAL COMPRESSION FRACTURE 5 0.0006
356 CLOSTRIDIUM DIFFICILE INFECTION 13 0.0006
357 POSTOPERATIVE WOUND INFECTION 4 0.0006
358 BLOOD IRON DECREASED 7 0.0006
359 BACTERAEMIA 7 0.0006
360 DIABETIC RETINOPATHY 2 0.0006
361 SLUGGISHNESS 6 0.0006
362 HIP ARTHROPLASTY 9 0.0006
363 HYPERLIPIDAEMIA 7 0.0006
364 LEFT VENTRICULAR FAILURE 2 0.0006
365 CERVICAL VERTEBRAL FRACTURE 2 0.0006
366 WEIGHT FLUCTUATION 6 0.0006
367 POST PROCEDURAL COMPLICATION 11 0.0006
368 SPINAL OSTEOARTHRITIS 5 0.0006
369 LYMPHOPENIA 8 0.0006
370 NYSTAGMUS 3 0.0006
371 TOOTH EXTRACTION 7 0.0006
372 INTENTIONAL DOSE OMISSION 16 0.0006
373 APPENDICECTOMY 2 0.0006
374 GINGIVITIS 3 0.0006
375 HIP SURGERY 3 0.0006
376 GASTROENTERITIS VIRAL 10 0.0006
377 BLOOD PRESSURE ABNORMAL 11 0.0006
378 BALANCE DISORDER 47 0.0005
379 AMYLASE INCREASED 2 0.0005
380 ARTHROPOD BITE 4 0.0005
381 HEAD INJURY 17 0.0005
382 DYSPNOEA 301 0.0005
383 TOOTH INFECTION 7 0.0005
384 CATHETER SITE INFECTION 2 0.0005
385 PERONEAL NERVE PALSY 3 0.0005
386 CHOLECYSTECTOMY 6 0.0005
387 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
388 HYPERSOMNIA 15 0.0005
389 EXERCISE TOLERANCE DECREASED 3 0.0005
390 NECK PAIN 29 0.0005
391 FATIGUE 404 0.0005
392 LIMB DISCOMFORT 16 0.0005
393 EYE DISORDER 17 0.0005
394 EATING DISORDER 11 0.0005
395 ABDOMINAL PAIN LOWER 13 0.0005
396 EPIGASTRIC DISCOMFORT 2 0.0005
397 THERAPEUTIC RESPONSE DECREASED 31 0.0005
398 URINE ODOUR ABNORMAL 3 0.0005
399 NASOPHARYNGITIS 94 0.0005
400 PNEUMONIA 165 0.0005
401 BRADYKINESIA 3 0.0005
402 PLEURISY 3 0.0005
403 SINUS HEADACHE 3 0.0005
404 INFLUENZA 56 0.0005
405 HYPERPHAGIA 2 0.0005
406 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
407 WHITE BLOOD CELL COUNT INCREASED 19 0.0005
408 DRY THROAT 5 0.0005
409 DECUBITUS ULCER 4 0.0005
410 MOTOR DYSFUNCTION 5 0.0005
411 MENISCUS INJURY 3 0.0005
412 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
413 STAPHYLOCOCCAL INFECTION 16 0.0005
414 CHOLANGITIS 3 0.0005
415 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
416 PETECHIAE 5 0.0005
417 ONYCHOMADESIS 2 0.0005
418 MUSCLE ATROPHY 6 0.0005
419 HEMIPARESIS 8 0.0005
420 SLEEP APNOEA SYNDROME 9 0.0005
421 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
422 LOWER LIMB FRACTURE 9 0.0005
423 CONTUSION 45 0.0005
424 HIP FRACTURE 15 0.0005
425 CARDIAC OPERATION 4 0.0005
426 HYPERPROLACTINAEMIA 3 0.0005
427 MUSCLE STRAIN 4 0.0005
428 HYSTERECTOMY 4 0.0005
429 PYELONEPHRITIS 4 0.0005
430 MELANOCYTIC NAEVUS 2 0.0005
431 ABDOMINAL ABSCESS 2 0.0005
432 ANKLE FRACTURE 7 0.0005
433 INFECTION 65 0.0004
434 BASAL CELL CARCINOMA 7 0.0004
435 SKIN INFECTION 5 0.0004
436 INTESTINAL PERFORATION 5 0.0004
437 HEAVY MENSTRUAL BLEEDING 4 0.0004
438 FEEDING DISORDER 9 0.0004
439 LIMB INJURY 12 0.0004
440 PNEUMOTHORAX 7 0.0004
441 RESPIRATORY TRACT CONGESTION 7 0.0004
442 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
443 URINARY INCONTINENCE 13 0.0004
444 PNEUMONIA BACTERIAL 4 0.0004
445 RETINAL DETACHMENT 4 0.0004
446 METASTASES TO LUNG 5 0.0004
447 BRONCHITIS 32 0.0004
448 LARGE INTESTINE PERFORATION 3 0.0004
449 BACK DISORDER 7 0.0004
450 APHONIA 6 0.0004
451 POST PROCEDURAL HAEMORRHAGE 5 0.0004
452 DIARRHOEA HAEMORRHAGIC 4 0.0004
453 CONDITION AGGRAVATED 130 0.0004
454 OXYGEN SATURATION DECREASED 24 0.0004
455 SURGERY 25 0.0004
456 DEVICE OCCLUSION 6 0.0004
457 SKIN REACTION 6 0.0004
458 PAPULE 3 0.0004
459 SQUAMOUS CELL CARCINOMA 4 0.0004
460 INFUSION RELATED REACTION 28 0.0004
461 BACK PAIN 98 0.0004
462 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
463 PARALYSIS 6 0.0004
464 GAIT INABILITY 14 0.0004
465 SKIN CANCER 9 0.0004
466 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
467 ILLNESS 43 0.0004
468 HUMERUS FRACTURE 2 0.0004
469 ATELECTASIS 4 0.0004
470 FAECES SOFT 3 0.0004
471 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
472 INTENTIONAL UNDERDOSE 3 0.0004
473 NASAL CONGESTION 24 0.0004
474 PANCREATIC DISORDER 2 0.0004
475 HOSPICE CARE 4 0.0004
476 MOVEMENT DISORDER 13 0.0004
477 SINUSITIS 41 0.0004
478 APHASIA 12 0.0004
479 PERIPHERAL SWELLING 61 0.0004
480 TOOTH ABSCESS 4 0.0004
481 LIPASE INCREASED 3 0.0004
482 BLOOD PRESSURE DECREASED 26 0.0004
483 EAR DISCOMFORT 4 0.0004
484 INFUSION SITE PAIN 5 0.0004
485 OEDEMA 21 0.0004
486 PELVIC FRACTURE 3 0.0004
487 EYE DISCHARGE 4 0.0004
488 RESTLESS LEGS SYNDROME 7 0.0004
489 RESPIRATORY FAILURE 28 0.0004
490 POLLAKIURIA 16 0.0004
491 ANAPHYLACTIC REACTION 21 0.0004
492 FOOD CRAVING 2 0.0004
493 IMMUNE SYSTEM DISORDER 5 0.0004
494 ILL-DEFINED DISORDER 23 0.0004
495 INCONTINENCE 4 0.0004
496 RENAL CYST 3 0.0004
497 RENAL PAIN 4 0.0004
498 CYSTITIS 12 0.0004
499 BACTERIAL INFECTION 7 0.0004
500 UTERINE CANCER 3 0.0004
501 MALIGNANT MELANOMA 5 0.0004
502 HEREDITARY ANGIOEDEMA 4 0.0004
503 PHOTOPHOBIA 7 0.0004
504 LOCALISED INFECTION 9 0.0004
505 BRUXISM 2 0.0004
506 MUSCLE SPASMS 68 0.0004
507 MUSCLE DISORDER 3 0.0004
508 SINUS CONGESTION 5 0.0004
509 PHARYNGITIS STREPTOCOCCAL 4 0.0004
510 FOOT FRACTURE 7 0.0004
511 SYSTEMIC LUPUS ERYTHEMATOSUS 13 0.0004
512 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
513 WOUND INFECTION 4 0.0004
514 CHOKING SENSATION 2 0.0004
515 RESPIRATORY DISTRESS 10 0.0004
516 HERNIA 7 0.0004
517 VIRAL INFECTION 12 0.0004
518 EAR PAIN 7 0.0004
519 NEOPLASM MALIGNANT 24 0.0004
520 HEART RATE ABNORMAL 2 0.0004
521 VISION BLURRED 49 0.0004
522 THROAT IRRITATION 16 0.0004
523 EYE INFECTION 4 0.0004
524 COLECTOMY 2 0.0004
525 BLOOD PRESSURE INCREASED 54 0.0004
526 PAIN IN JAW 10 0.0004
527 CHOLECYSTITIS ACUTE 2 0.0004
528 DIALYSIS 5 0.0004
529 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
530 PRODUCT AVAILABILITY ISSUE 8 0.0004
531 CARDIAC VALVE DISEASE 2 0.0003
532 COUGH 98 0.0003
533 ENTEROCOLITIS 2 0.0003
534 HYPOKINESIA 5 0.0003
535 ELECTROLYTE IMBALANCE 4 0.0003
536 BODY TEMPERATURE INCREASED 7 0.0003
537 SYRINGE ISSUE 6 0.0003
538 GASTROENTERITIS 5 0.0003
539 RHINORRHOEA 22 0.0003
540 ATAXIA 4 0.0003
541 CEREBRAL HAEMORRHAGE 12 0.0003
542 MACULAR DEGENERATION 4 0.0003
543 POLYNEUROPATHY 4 0.0003
544 WRIST FRACTURE 4 0.0003
545 THYROID CANCER 4 0.0003
546 GANGRENE 2 0.0003
547 LEUKOCYTOSIS 6 0.0003
548 BURSITIS 4 0.0003
549 EXOSTOSIS 3 0.0003
550 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
551 NERVE COMPRESSION 3 0.0003
552 OROPHARYNGEAL PAIN 30 0.0003
553 PRODUCT DOSE OMISSION ISSUE 95 0.0003
554 HEPATIC STEATOSIS 6 0.0003
555 WOUND 9 0.0003
556 APPENDICITIS 3 0.0003
557 FLANK PAIN 3 0.0003
558 NASAL DRYNESS 2 0.0003
559 GAIT DISTURBANCE 61 0.0003
560 SPINAL DISORDER 3 0.0003
561 BLOOD URINE PRESENT 6 0.0003
562 ANGINA PECTORIS 9 0.0003
563 SCIATICA 5 0.0003
564 ABSCESS 5 0.0003
565 HEART RATE DECREASED 11 0.0003
566 INTRAOCULAR PRESSURE INCREASED 4 0.0003
567 SNEEZING 7 0.0003
568 ACUTE RESPIRATORY FAILURE 6 0.0003
569 VERTIGO 19 0.0003
570 GLAUCOMA 6 0.0003
571 THROMBOSIS 25 0.0003
572 ROAD TRAFFIC ACCIDENT 13 0.0003
573 DIZZINESS POSTURAL 3 0.0003
574 BLOOD POTASSIUM INCREASED 5 0.0003
575 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
576 HEADACHE 192 0.0003
577 VITREOUS FLOATERS 3 0.0003
578 ORAL CANDIDIASIS 4 0.0003
579 LIGAMENT SPRAIN 3 0.0003
580 BLADDER DISORDER 3 0.0003
581 DIABETES MELLITUS 23 0.0003
582 ADVERSE REACTION 4 0.0003
583 EAR INFECTION 8 0.0003
584 DEHYDRATION 40 0.0003
585 URINARY RETENTION 10 0.0003
586 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
587 CHILLS 35 0.0003
588 VISUAL IMPAIRMENT 37 0.0003
589 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
590 THROAT TIGHTNESS 8 0.0003
591 NEUTROPHIL COUNT INCREASED 3 0.0003
592 CHEST DISCOMFORT 30 0.0003
593 MALAISE 128 0.0003
594 UNEVALUABLE EVENT 22 0.0003
595 LYMPHOEDEMA 2 0.0003
596 PRESYNCOPE 7 0.0003
597 FEELING COLD 8 0.0003
598 METASTASES TO LIVER 5 0.0003
599 COLD SWEAT 5 0.0003
600 TREMOR 47 0.0003
601 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
602 SKIN DISCOLOURATION 13 0.0003
603 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
604 DIVERTICULUM 2 0.0003
605 HYPOAESTHESIA 42 0.0003
606 POOR QUALITY SLEEP 6 0.0003
607 PARAESTHESIA ORAL 4 0.0003
608 MYALGIA 47 0.0003
609 OSTEOMYELITIS 5 0.0003
610 SEPTIC SHOCK 12 0.0003
611 BLOOD GLUCOSE FLUCTUATION 3 0.0003
612 NEUROPATHY PERIPHERAL 26 0.0003
613 DYSURIA 10 0.0003
614 ACUTE MYOCARDIAL INFARCTION 8 0.0003
615 UNRESPONSIVE TO STIMULI 7 0.0003
616 BLINDNESS TRANSIENT 2 0.0003
617 FOOT DEFORMITY 3 0.0003
618 HAEMATOMA 7 0.0003
619 FUNGAL INFECTION 9 0.0003
620 TRANSAMINASES INCREASED 6 0.0003
621 FEELING DRUNK 2 0.0003
622 PAIN IN EXTREMITY 79 0.0003
623 LUNG NEOPLASM MALIGNANT 11 0.0003
624 OCULAR DISCOMFORT 3 0.0003
625 JOINT STIFFNESS 7 0.0003
626 PAROSMIA 2 0.0003
627 PANCREATITIS 14 0.0003
628 FRACTURE 5 0.0003
629 HEART RATE INCREASED 26 0.0003
630 FEELING JITTERY 5 0.0003
631 EPILEPSY 8 0.0003
632 CARDIAC FAILURE CONGESTIVE 21 0.0003
633 NEOPLASM 3 0.0003
634 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
635 ATRIOVENTRICULAR BLOCK 2 0.0003
636 APHTHOUS ULCER 2 0.0003
637 LOSS OF CONSCIOUSNESS 33 0.0003
638 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
639 ORAL HERPES 5 0.0003
640 SKIN LESION 7 0.0003
641 PULMONARY EMBOLISM 24 0.0003
642 SINUS DISORDER 5 0.0003
643 FURUNCLE 2 0.0003
644 CHOLECYSTITIS 3 0.0003
645 GINGIVAL PAIN 2 0.0003
646 FEELING ABNORMAL 60 0.0003
647 BLOOD PRESSURE FLUCTUATION 6 0.0002
648 RENAL IMPAIRMENT 21 0.0002
649 BLOOD DISORDER 2 0.0002
650 EYE PAIN 14 0.0002
651 NOCTURIA 3 0.0002
652 CARDIAC DISORDER 23 0.0002
653 ASPHYXIA 2 0.0002
654 ENCEPHALOPATHY 6 0.0002
655 HICCUPS 2 0.0002
656 HYPERAESTHESIA 2 0.0002
657 ESCHERICHIA INFECTION 2 0.0002
658 OSTEOPOROSIS 10 0.0002
659 CHEST PAIN 45 0.0002
660 PHOTOSENSITIVITY REACTION 4 0.0002
661 EMBOLISM 2 0.0002
662 CYTOMEGALOVIRUS INFECTION 4 0.0002
663 INJECTION SITE DISCOLOURATION 3 0.0002
664 PEMPHIGUS 3 0.0002
665 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
666 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
667 PROSTATE CANCER 19 0.0002
668 FLUID RETENTION 12 0.0002
669 ERECTILE DYSFUNCTION 6 0.0002
670 WEIGHT INCREASED 52 0.0002
671 HEPATIC FAILURE 7 0.0002
672 SKIN ULCER 6 0.0002
673 DISEASE RECURRENCE 11 0.0002
674 CARDIAC MURMUR 2 0.0002
675 DELIRIUM 8 0.0002
676 SWELLING FACE 15 0.0002
677 PARAESTHESIA 36 0.0002
678 GROIN PAIN 2 0.0002
679 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
680 DRUG ERUPTION 4 0.0002
681 WEIGHT DECREASED 63 0.0002
682 BREAST CANCER FEMALE 6 0.0002
683 SWOLLEN TONGUE 7 0.0002
684 GALLBLADDER DISORDER 4 0.0002
685 FACIAL PAIN 2 0.0002
686 QUALITY OF LIFE DECREASED 3 0.0002
687 HAEMOLYTIC ANAEMIA 2 0.0002
688 GOUT 4 0.0002
689 DEATH 191 0.0002
690 CHROMATURIA 5 0.0002
691 TOOTHACHE 4 0.0002
692 IMPAIRED GASTRIC EMPTYING 3 0.0002
693 DIARRHOEA 142 0.0002
694 C-REACTIVE PROTEIN INCREASED 8 0.0002
695 ARTHRALGIA 91 0.0002
696 INFLUENZA LIKE ILLNESS 18 0.0002
697 PERIPHERAL COLDNESS 3 0.0002
698 BRAIN NEOPLASM 2 0.0002
699 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
700 BLOOD GLUCOSE ABNORMAL 4 0.0002
701 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
702 OSTEONECROSIS 7 0.0002
703 BLOOD SODIUM DECREASED 4 0.0002
704 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
705 RED BLOOD CELL COUNT DECREASED 6 0.0002
706 DIABETIC KETOACIDOSIS 5 0.0002
707 HEPATIC CANCER 5 0.0002
708 GENERAL PHYSICAL HEALTH DETERIORATION 24 0.0002
709 INJECTION SITE HAEMATOMA 3 0.0002
710 INTENTIONAL PRODUCT USE ISSUE 18 0.0002
711 ANAEMIA 39 0.0002
712 OFF LABEL USE 178 0.0002
713 DISORIENTATION 8 0.0002
714 INABILITY TO AFFORD MEDICATION 2 0.0002
715 COLON CANCER 3 0.0002
716 ADVERSE DRUG REACTION 18 0.0002
717 HYPOTONIA 2 0.0002
718 OVARIAN CYST 2 0.0002
719 SYNCOPE 20 0.0002
720 CARDIAC FAILURE 16 0.0002
721 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
722 FLUSHING 20 0.0002
723 PYREXIA 68 0.0002
724 MOBILITY DECREASED 14 0.0002
725 DIZZINESS 96 0.0002
726 MENINGIOMA 3 0.0002
727 HYPERGLYCAEMIA 7 0.0002
728 ARTHRITIS 15 0.0002
729 ARRHYTHMIA 9 0.0002
730 HALLUCINATION, VISUAL 4 0.0002
731 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
732 JOINT DISLOCATION 2 0.0002
733 MIGRAINE 18 0.0002
734 EYE SWELLING 7 0.0002
735 HYPOTHYROIDISM 6 0.0002
736 COLITIS 7 0.0002
737 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
738 SLEEP DISORDER 13 0.0002
739 SOMNOLENCE 37 0.0002
740 MUSCULOSKELETAL STIFFNESS 16 0.0002
741 DENTAL CARIES 2 0.0002
742 PROCEDURAL PAIN 5 0.0002
743 SKIN DISORDER 6 0.0002
744 NAUSEA 141 0.0002
745 FISTULA 2 0.0002
746 MYOCARDIAL INFARCTION 31 0.0002
747 CANDIDA INFECTION 3 0.0002
748 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
749 MYOCARDITIS 2 0.0002
750 RASH MACULAR 6 0.0002
751 HYPOXIA 6 0.0002
752 BRADYCARDIA 9 0.0002
753 PLATELET COUNT DECREASED 18 0.0002
754 TACHYCARDIA 15 0.0002
755 ASTHMA 19 0.0002
756 ACCIDENT 2 0.0002
757 BLOOD GLUCOSE DECREASED 8 0.0002
758 INSOMNIA 44 0.0002
759 DRUG INEFFECTIVE 216 0.0002
760 ABDOMINAL PAIN 38 0.0002
761 FEELING HOT 10 0.0002
762 HYPERHIDROSIS 21 0.0002
763 CONJUNCTIVITIS 3 0.0002
764 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
765 ILEUS 2 0.0002
766 MENTAL DISORDER 7 0.0002
767 HYPERTENSION 34 0.0002
768 AGEUSIA 4 0.0002
769 DRY EYE 8 0.0002
770 HEPATIC CIRRHOSIS 3 0.0002
771 DERMATITIS ALLERGIC 2 0.0002
772 LIVER DISORDER 7 0.0002
773 GASTRIC ULCER 3 0.0002
774 CARDIOVASCULAR DISORDER 4 0.0002
775 LETHARGY 9 0.0002
776 PULMONARY FIBROSIS 3 0.0002
777 NIGHT SWEATS 5 0.0002
778 ANAPHYLACTIC SHOCK 4 0.0002
779 PAIN 95 0.0002
780 DEPRESSION 35 0.0002
781 ECZEMA 8 0.0002
782 CHOLELITHIASIS 5 0.0002
783 IMPAIRED HEALING 5 0.0002
784 WHEEZING 9 0.0002
785 HYPERSENSITIVITY 28 0.0002
786 COGNITIVE DISORDER 7 0.0001
787 EYE HAEMORRHAGE 2 0.0001
788 HYPOTENSION 30 0.0001
789 PRODUCT PHYSICAL ISSUE 3 0.0001
790 TYPE 2 DIABETES MELLITUS 5 0.0001
791 TASTE DISORDER 3 0.0001
792 CORONARY ARTERY OCCLUSION 2 0.0001
793 GASTROINTESTINAL DISORDER 13 0.0001
794 HAEMATOCHEZIA 8 0.0001
795 PERITONITIS 3 0.0001
796 HYPOGLYCAEMIA 7 0.0001
797 DEMENTIA 4 0.0001
798 ABDOMINAL DISCOMFORT 24 0.0001
799 LUNG DISORDER 7 0.0001
800 CARPAL TUNNEL SYNDROME 2 0.0001
801 BURNING SENSATION 10 0.0001
802 BLISTER 8 0.0001
803 BLOOD TEST ABNORMAL 2 0.0001
804 DECREASED APPETITE 33 0.0001
805 BLINDNESS UNILATERAL 2 0.0001
806 CEREBROVASCULAR ACCIDENT 24 0.0001
807 ANXIETY 40 0.0001
808 IMPAIRED WORK ABILITY 3 0.0001
809 BRONCHOSPASM 2 0.0001
810 LIVER FUNCTION TEST INCREASED 3 0.0001
811 RECTAL HAEMORRHAGE 6 0.0001
812 OEDEMA PERIPHERAL 17 0.0001
813 EYE IRRITATION 8 0.0001
814 SWELLING 13 0.0001
815 PANCREATIC CARCINOMA 4 0.0001
816 DEEP VEIN THROMBOSIS 9 0.0001
817 HYPERTHYROIDISM 2 0.0001
818 PRODUCT DISPENSING ERROR 3 0.0001
819 PANIC ATTACK 5 0.0001
820 LABORATORY TEST ABNORMAL 4 0.0001
821 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
822 MUSCULOSKELETAL PAIN 7 0.0001
823 PANCREATITIS ACUTE 3 0.0001
824 CARDIAC ARREST 11 0.0001
825 HOT FLUSH 10 0.0001
826 DEPRESSED MOOD 7 0.0001
827 INJECTION SITE RASH 4 0.0001
828 FEMUR FRACTURE 4 0.0001
829 BREAST CANCER 12 0.0001
830 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
831 EJECTION FRACTION DECREASED 2 0.0001
832 TREATMENT NONCOMPLIANCE 7 0.0001
833 CYANOSIS 2 0.0001
834 ABNORMAL BEHAVIOUR 5 0.0001
835 COMA 6 0.0001
836 HALLUCINATION, AUDITORY 2 0.0001
837 PRODUCT STORAGE ERROR 11 0.0001
838 RASH ERYTHEMATOUS 6 0.0001
839 ABDOMINAL DISTENSION 13 0.0001
840 MENTAL IMPAIRMENT 3 0.0001
841 CONFUSIONAL STATE 20 0.0001
842 UNDERDOSE 9 0.0001
843 PSORIATIC ARTHROPATHY 5 0.0001
844 MULTIPLE FRACTURES 2 0.0001
845 VOMITING 57 0.0001
846 EPISTAXIS 9 0.0001
847 COAGULOPATHY 2 0.0001
848 BLOOD UREA INCREASED 2 0.0001
849 BLADDER CANCER 7 0.0001
850 FACE OEDEMA 2 0.0001
851 SKIN EXFOLIATION 10 0.0001
852 CHRONIC KIDNEY DISEASE 9 0.0001
853 CIRCULATORY COLLAPSE 2 0.0001
854 HEPATIC ENZYME INCREASED 8 0.0001
855 HAEMOGLOBIN DECREASED 12 0.0001
856 DRUG RESISTANCE 3 0.0001
857 ABDOMINAL PAIN UPPER 24 0.0001
858 VAGINAL HAEMORRHAGE 5 0.0001
859 NERVOUSNESS 6 0.0001
860 HAEMORRHAGE 12 0.0001
861 DISCOMFORT 7 0.0001
862 DEAFNESS 3 0.0001
863 LYMPHOCYTE COUNT DECREASED 2 0.0001
864 SEIZURE 13 0.0001
865 ALOPECIA 22 0.0001
866 PULMONARY OEDEMA 5 0.0001
867 FREQUENT BOWEL MOVEMENTS 3 0.0001
868 RASH PRURITIC 6 0.0001
869 HYPOKALAEMIA 5 0.0001
870 JOINT SWELLING 13 0.0001
871 RENAL DISORDER 5 0.0001
872 BLOOD CREATININE INCREASED 7 0.0001
873 HEPATIC FUNCTION ABNORMAL 4 0.0001
874 INTESTINAL OBSTRUCTION 4 0.0001
875 INCREASED APPETITE 2 0.0001
876 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
877 PRURITUS 40 0.0001
878 DYSTONIA 2 0.0001
879 HAEMORRHOIDS 2 0.0001
880 PLASMA CELL MYELOMA 4 0.0001
881 BONE PAIN 6 0.0001
882 MEMORY IMPAIRMENT 14 0.0001
883 DISABILITY 2 0.0001
884 BLOOD POTASSIUM DECREASED 3 0.0001
885 EMOTIONAL DISTRESS 12 0.0001
886 CORONARY ARTERY DISEASE 3 0.0001
887 DRY MOUTH 8 0.0001
888 DYSKINESIA 4 0.0001
889 DRUG-INDUCED LIVER INJURY 3 0.0001
890 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
891 PALPITATIONS 11 0.0001
892 HYPOACUSIS 4 0.0001
893 ERYTHEMA 19 0.0001
894 FAECES DISCOLOURED 2 0.0001
895 DEVICE DISLOCATION 4 0.0001
896 INJECTION SITE SWELLING 7 0.0001
897 INJECTION SITE PAIN 28 0.0001
898 LIP SWELLING 3 0.0001
899 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
900 ORAL PAIN 2 0.0001
901 EYE PRURITUS 3 0.0001
902 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
903 ANGER 3 0.0001
904 HEART RATE IRREGULAR 2 0.0001
905 DRUG INTERACTION 14 0.0001
906 FLATULENCE 5 0.0001
907 BLOOD CHOLESTEROL INCREASED 4 0.0001
908 HYPERKALAEMIA 3 0.0001
909 TREATMENT FAILURE 7 0.0001
910 RENAL CANCER 4 0.0001
911 MYELOSUPPRESSION 3 0.0001
912 INCORRECT DOSE ADMINISTERED 19 0.0001
913 RENAL FAILURE 11 0.0001
914 FIBROMYALGIA 2 0.0001
915 NEURALGIA 2 0.0001
916 PLEURAL EFFUSION 5 0.0001
917 RESTLESSNESS 3 0.0001
918 INJECTION SITE URTICARIA 2 0.0001
919 DYSGEUSIA 6 0.0001
920 INJECTION SITE ERYTHEMA 10 0.0001
921 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
922 EXPOSURE DURING PREGNANCY 5 0.0001
923 HALLUCINATION 6 0.0001
924 HYPOPHAGIA 2 0.0001
925 URTICARIA 13 0.0001
926 GASTRITIS 2 0.0001
927 RASH 33 0.0001
928 INJECTION SITE PRURITUS 5 0.0001
929 JAUNDICE 2 0.0001
930 PAIN OF SKIN 2 0.0001
931 BLOOD BILIRUBIN INCREASED 2 0.0001
932 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
933 BLINDNESS 3 0.0001
934 NEUTROPHIL COUNT DECREASED 3 0.0001
935 PALLOR 2 0.0001
936 CONSTIPATION 16 0.0001
937 MOOD ALTERED 2 0.0001
938 ABNORMAL DREAMS 2 0.0001
939 ARTHROPATHY 4 0.0001
940 HAEMOPTYSIS 2 0.0001
941 OSTEOARTHRITIS 3 0.0001
942 SKIN BURNING SENSATION 5 0.0001
943 AGITATION 5 0.0001
944 ASCITES 2 0.0001
945 ANGIOEDEMA 3 0.0001
946 DISEASE PROGRESSION 8 0.0001
947 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
948 MOOD SWINGS 2 0.0001
949 INTERSTITIAL LUNG DISEASE 3 0.0001
950 RHEUMATOID ARTHRITIS 7 0.0001
951 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
952 AMNESIA 4 0.0001
953 ACUTE KIDNEY INJURY 9 0.0001
954 HAEMATURIA 2 0.0001
955 BLOOD GLUCOSE INCREASED 11 0.0001
956 NIGHTMARE 2 0.0001
957 LYMPHADENOPATHY 2 0.0001
958 PRODUCT USE IN UNAPPROVED INDICATION 14 0.0001
959 DISTURBANCE IN ATTENTION 3 0.0001
960 CRYING 2 0.0001
961 ACCIDENTAL OVERDOSE 2 0.0001
962 ADVERSE EVENT 5 0.0001
963 INJECTION SITE MASS 2 0.0001
964 PANCYTOPENIA 3 0.0001
965 PSORIASIS 7 0.0001
966 DRY SKIN 6 0.0000
967 NEUTROPENIA 6 0.0000
968 INJECTION SITE REACTION 3 0.0000
969 OCULAR HYPERAEMIA 2 0.0000
970 INFLAMMATION 2 0.0000
971 NO ADVERSE EVENT 7 0.0000
972 INJECTION SITE BRUISING 3 0.0000
973 MEDICATION ERROR 2 0.0000
974 THROMBOCYTOPENIA 4 0.0000
975 IRRITABILITY 2 0.0000
976 PRODUCT USE ISSUE 6 0.0000
977 DRUG INTOLERANCE 3 0.0000
978 DYSPEPSIA 3 0.0000
979 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
980 DEVICE MALFUNCTION 2 0.0000
981 ACNE 2 0.0000
982 INJECTION SITE HAEMORRHAGE 2 0.0000
983 COMPLETED SUICIDE 2 0.0000
984 OVERDOSE 5 0.0000
985 INTENTIONAL PRODUCT MISUSE 2 0.0000
986 DEVICE ISSUE 2 0.0000
987 DRUG DEPENDENCE 2 0.0000